ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Publishes FOA For Trials Network Program

July 27, 2012

NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost

March 8, 1996

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Klausner To Revamp NCI Budget Process To Make Categories Mean What They Say

December 8, 1995

Two-Month Longer Survival Found With Gliadel Wafer

March 31, 2006